An open trial of cognitive behavioral therapy with contingency management for hoarding disorder

2017 ◽  
Vol 12 ◽  
pp. 78-86 ◽  
Author(s):  
Blaise L. Worden ◽  
William M. Bowe ◽  
David F. Tolin
Keyword(s):  
Cognitive Behavioral Therapy ◽  
Behavioral Therapy ◽  
Contingency Management ◽  
Open Trial ◽  
Cognitive Behavioral ◽  
Hoarding Disorder

Group cognitive-behavioral therapy for hoarding disorder: An open trial

2011 ◽  
Vol 49 (11) ◽  
pp. 802-807 ◽  
Author(s):  
Christina M. Gilliam ◽  
Melissa M. Norberg ◽  
Anna Villavicencio ◽  
Samantha Morrison ◽  
Scott E. Hannan ◽  
...  
Keyword(s):  
Cognitive Behavioral Therapy ◽  
Behavioral Therapy ◽  
Open Trial ◽  
Cognitive Behavioral ◽  
Hoarding Disorder

COGNITIVE BEHAVIORAL THERAPY FOR HOARDING DISORDER: A META-ANALYSIS

2015 ◽  
Vol 32 (3) ◽  
pp. 158-166 ◽  
Author(s):  
David F. Tolin ◽  
Randy O. Frost ◽  
Gail Steketee ◽  
Jordana Muroff
Keyword(s):  
Cognitive Behavioral Therapy ◽  
Behavioral Therapy ◽  
Meta Analysis ◽  
Cognitive Behavioral ◽  
Hoarding Disorder

scholarly journals Hoarding to the heart’s content: a case series and detailed case report of hoarding treatment in heart failure

2021 ◽  
Author(s):  
Phillip Tully ◽  
Suzanne Cosh ◽  
Bethany Wootton
Keyword(s):  
Heart Failure ◽  
Case Report ◽  
Cognitive Behavioral Therapy ◽  
Cardiovascular Response ◽  
Behavioral Therapy ◽  
Case Series ◽  
Cognitive Behavioral ◽  
Hoarding Disorder ◽  
Patients With Heart Failure ◽  
Detailed Case Report

Hoarding disorder (HD) is characterized by an accumulation of possessions due to excessive acquisition of, or difficulty discarding possessions. Evidence demonstrates an increased cardiovascular response in patients with HD. Cognitive-behavioral therapy modifications are described for HD patients with heart failure to compensate for fatigability, syncope and falls risk.

An Open Trial of Intensive Cognitive-Behavioral Therapy for School Refusal

2019 ◽  
Vol 4 (1) ◽  
pp. 89-101 ◽  
Author(s):  
Scott Hannan ◽  
Elizabeth Davis ◽  
Samantha Morrison ◽  
Ralitza Gueorguieva ◽  
David F. Tolin
Keyword(s):  
Cognitive Behavioral Therapy ◽  
Behavioral Therapy ◽  
School Refusal ◽  
Open Trial ◽  
Cognitive Behavioral

Feasibility and Acceptability of reSET-O®: Patient and Provider Reported Experiences in a Pilot Study of a Novel Digital Therapeutic in People with Opioid Use Disorder (Preprint)

2021 ◽  
Author(s):  
Sarah Kawasaki ◽  
Sara Mills-Huffnagle ◽  
Nicole Aydinoglo ◽  
Halley Maxin ◽  
Edward Nunes
Keyword(s):  
Pilot Study ◽  
Cognitive Behavioral Therapy ◽  
Behavioral Treatment ◽  
Behavioral Therapy ◽  
Contingency Management ◽  
Opioid Use Disorder ◽  
Cognitive Behavioral ◽  
Opioid Use ◽  
Hub And Spoke ◽  
Buprenorphine Treatment

BACKGROUND Medications for treatment of opioid use disorder (OUD), such as buprenorphine, are effective and essential for addressing the opioid epidemic. However, high dropout rates from medication remain a challenge. Behavioral treatment with contingency management plus cognitive behavioral counseling has shown promise for improving outcomes of buprenorphine treatment, but is complicated to deliver. Delivery of behavioral treatment through technology-based platforms has the potential to make it more feasible for widespread dissemination. OBJECTIVE reSET-O® is a Prescription Digital Therapeutic and a commercial adaptation of the Therapeutic Education System, an internet-based, interactive program with a Community Reinforcement Approach to cognitive behavioral therapy. It delivers cognitive behavioral therapy modules and contingency management rewards upon completion of modules and negative urine drug screens. A pilot study was performed to assess feasibility and acceptability of reSET-O® in a Hub and Spoke model of care as part of a larger strategy to maintain individuals in treatment. Objective and qualitative results, as well as acceptability and likeability of reSET-O®, were obtained from fifteen individuals. METHODS English-speaking individuals over the age of 18 with a diagnosis of current OUD were recruited after being on buprenorphine for at least one week of treatment. Two 12-week prescriptions for reSET-O® were written for a 24-week study. Patient report of drug use and likeability scales of reSET-O® were conducted at weeks 4,8, 12 and 24 of the study. Qualitative interviews were also conducted. Four providers were recruited and gave feedback on the acceptability and feasibility of reSET-O®. RESULTS Of 15 participants who entered this pilot study, 7 completed 24 weeks and 8 were unable to complete due to drop out after enrollment, attrition in treatment, or incarceration. An average of $96 in contingency management rewards were earned by the participants for completion of modules for the duration of the pilot study. Participants’ subjective feedback found that reSET-O® was easy to use, enjoyable, and helped provide a safe space to admit recurring substance use. CONCLUSIONS ReSET-O® was well accepted based on patient and provider feedback in this pilot study, but adherence and retention in treatment remain areas for improvement, as with traditional MOUD and CBT approaches. A randomized control trial in a Hub and Spoke model will be needed to assess if retention on buprenorphine treatment is enhanced through the use of technology based behavioral interventions such as reSET-O®. CLINICALTRIAL NCT03826966

Sign in / Sign up

Export Citation Format

Share Document